Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C.

E R Jenny-Avital1

  • 1Jacobi Medical Center, Suite 607, Van Etten, 1400 Pelham Parkway South, Bronx, NY 10461, USA.

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus infection often leads to chronic liver disease due to immune system failure and viral genetic diversity. Treatment with interferon and ribavirin shows effectiveness in a minority of patients with early-stage disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HCV-coinfection is associated with diabetes and CD4 decline.

AIDS clinical care·2003
Same author

Triple PI therapy--perhaps more is not better.

AIDS clinical care·2003
Same author

Resistance: a shifting paradigm.

AIDS clinical care·2003
Same author

Timing is everything.

AIDS clinical care·2002
Same author

HCV in an HIV-infected man.

AIDS clinical care·2001
Same author

Occult gastrointestinal Kaposi's sarcoma in an HIV-infected African man.

AIDS clinical care·2001
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide.
  • HCV infection is characterized by immune system evasion, liver damage from cytotoxic T lymphocytes, and rapid genetic evolution.
  • Disease progression is often asymptomatic and influenced by host factors like sex, age, alcohol consumption, and immune status.

Purpose of the Study:

  • To summarize the key characteristics of Hepatitis C virus infection.
  • To outline the factors influencing disease progression.
  • To describe current therapeutic options and their efficacy.

Main Methods:

  • Review of existing literature on Hepatitis C virus.
  • Analysis of factors contributing to chronicity and progression.

Related Experiment Videos

  • Evaluation of the effectiveness of interferon and ribavirin therapies.

    • Main Results:

    • HCV infection leads to chronic liver disease through immune dysfunction and viral diversity.
    • Progression is silent and multifactorial, influenced by patient-specific characteristics.
    • Interferon and ribavirin are effective for a subset of patients with early-stage fibrosis and low viral loads.

    Conclusions:

    • Hepatitis C virus infection presents a complex interplay between the virus, the immune system, and host factors.
    • Effective treatment is limited to a specific patient group, highlighting the need for further therapeutic development.